Concepedia

Author

Bernadette Lázár

Semmelweis UniversityORCID

Also Known As

B Lazar, B. Lazar, B. Petre Lazar, Bernadette Lazar, Bernadette Lázár

14

Publications

159

Citations

7

H-Index

23

Concepts

All Affiliations

Semmelweis UniversityUniversity of PecsPázmány Péter Catholic UniversityUniversity of SzegedHUN-REN Szegedi Biológiai Kutatóközpont
BL

About

Bernadette Lázár is an author at Semmelweis University specializing in inflammation, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

62

2

Health Sciences

1

1

26

3

Allergy

1

1

36

4

Anesthesia

1

1

26

5

Gastroenterology

1

1

36

Bernadette Lázár

×

7

Publications

144

Citations

7

H-Index

YearCitations

A comprehensive time course and correlation analysis of indomethacin-induced inflammation, bile acid alterations and dysbiosis in the rat small intestine

Bernadette Lázár, Szilvia B. László, Barbara Hutka,

Biochemical Pharmacology

2021

36

The Peripheral Versus Central Antinociception of a Novel Opioid Agonist: Acute Inflammatory Pain in Rats

Mihály Balogh, Zoltán Zádori, Bernadette Lázár,

Neurochemical Research

2018

26

Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion

Gábor B. Brenner, András Makkos, Csilla Terézia Nagy,

Cells

2020

25

Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats

Mihály Balogh, Ferenc Zádor, Zoltán Zádori,

Frontiers in Pharmacology

2019

24

The Nonsteroidal Anti-Inflammatory Drug Ketorolac Alters the Small Intestinal Microbiota and Bile Acids Without Inducing Intestinal Damage or Delaying Peristalsis in the Rat

Barbara Hutka, Bernadette Lázár, András S. Tóth,

Frontiers in Pharmacology

2021

12

Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in rats

Szilvia B. László, Bernadette Lázár, Gábor B. Brenner,

Biochemical Pharmacology

2020

11

Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat

Bernadette Lázár, Gábor B. Brenner, András Makkos,

Cells

2019

10

Page 1